CareDx Strengthens Bioinformatics Capabilities with Acquisition of BFS Molecular
March 17, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., March 17, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Names Ankur Dhingra as New Chief Financial Officer
March 11, 2021 16:05 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Expands into the Pre-Transplant Kidney Space through TX Connect
February 25, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Reports Fourth Quarter and Full Year 2020 Results
February 24, 2021 16:01 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
Spotlight on the CareDx’s Symposium at the Upcoming Cutting Edge of Transplantation (CEoT) Meeting
February 23, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx to Report Fourth Quarter and Full Year 2020 Financial Results
February 12, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 11, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx to to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 10, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Showcases Cellular Transplantation and Therapy Portfolio at TCT
February 05, 2021 07:00 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
CareDx Announces Closing of Public Offering of Common Stock
January 25, 2021 16:28 ET
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of...